tocilizumab
Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tocilizumab (Actemra) | SOLUTION, INTRAVENOUS | 20 mg/mL (10 mL) | ||||||||||||||
Tocilizumab (Actemra) | SOLUTION, INTRAVENOUS | 20 mg/mL (20 mL) | ||||||||||||||
Tocilizumab (Actemra) | SOLUTION, INTRAVENOUS | 20 mg/mL (4 mL) | ||||||||||||||
Tocilizumab-aazg (Tyenne) | SOLUTION, INTRAVENOUS | 20 mg/mL (4 mL) | ||||||||||||||
Tocilizumab-aazg (Tyenne) | SOLUTION, INTRAVENOUS | 20 mg/mL (10 mL) | ||||||||||||||
Tocilizumab-aazg (Tyenne) | SOLUTION, INTRAVENOUS | 20 mg/mL (20 mL) |
UNC Health
System Formulary Restriction:
Use of Actemra injection is restricted to patients who meet one of the following criteria:
UNC Health IV Compendium Guideline
Med Center
UNC Medical Center Formulary Restrictions
Adult Inpatients with COVID-19 Guideline